← Back
$BTAI All transactions

BioXcel Therapeutics, Inc.

M

$ Value

Shares

35

Price

Filed

Sep 16

Insider

Name

Steinhart Richard I

Title

Chief Financial Officer

CIK

0001293789

Roles

Officer

Transaction Details

Transaction Date

2025-09-15

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,509

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | On March 14, 2022, the Reporting Person was granted 521 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. | On March 15, 2023, the Reporting Person was granted 562 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Filing Info

Accession No.

0001104659-25-090517

Form Type

4

Issuer CIK

0001720893

Steinhart Richard I's History

Date Ticker Type Value
2026-03-15 BTAI M
2026-03-15 BTAI M $0
2026-03-14 BTAI M
2026-03-14 BTAI M $0
2026-01-01 BTAI A $0
2025-12-15 BTAI M
2025-12-15 BTAI M $0
2025-12-14 BTAI M
2025-12-14 BTAI M $0
2025-09-15 BTAI M

Other Insiders at BTAI (90d)

Insider Bought Sold Last
Steinhart Richard I
Chief Financial Officer
2026-03-15
Yocca Frank
Chief Scientific Officer
2026-03-15
Mehta Vimal
CEO and President
2026-03-15
Rodriguez Javier
See Remarks
2026-03-15